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Incidence of anal cancer is increasing and risk of anal cancer is higher in MSM, especially if they are HIV. European guidelines
for treatment of HIV-infected adults recommend anal cancer screening by digital rectal exam9Pap test with anuscopy if Pap test
is abnormal. A systematic anal cancer screening in HIVMSM with anal cytology (Pap smears) was established in June 2011 in
our reference centre in Brussels. If anal cytology was abnormal, high-resolution anuscopy (HRA) with biopsy was performed.
353 MSM HIVwere screened by anal smears between June 2011 and May 2012. 90% were Caucasians, median age was
44.5 years, 83% were on HAART and 74% had an undetectable viral load, median CD4 was 632/ml and 33% had a nadir
CD4B200. Thirty-three (9.3%) were excluded because of poor quality. Cytology was abnormal in 46% of the 320 remaining
patients: high-grade squamous intraepithelial lesion (HSIL) 3%, low-grade squamous intraepithelial lesion (LSIL) 24%, atypical
squamous cells of undetermined significance (ASC-US) 16%, and atypical squamous cells / cannot rule out a high-grade lesion
(ASC-H) 3%. Viral load (VL) was more frequently undetectable (82% vs 64%, p0.0003) and median duration of HAART was
longer (111 vs 61 months, p0.0145) in patients with normal cytology. 80 HRA with biopsies have been performed. 12.5% were
normal, 44% showed anal intraepithelial neoplasia (AIN) 1, 24% AIN 2 and 19% AIN 3. For this analysis, high-grade AIN (2 and 3)
were put together (AIN 2). Among patients with AIN 2(n33), cytology had showed 8 (24%) ASC-US, 3 (9%) ASC-H, 19
(57%) LSIL, 3 (9%) HSIL. When patients with normal cytology or normal biopsy and patients with AIN 2were compared, the
only significant risk factor found for AIN 2was a nadir CD4B100/ml (32% of the patients with AIN 2vs 14% in patients with
normal smear, p0.0073). Anal precancerous lesions are frequent and at different stages. Among 46% abnormal cytology,
87% had abnormal biopsy including half AIN 2.Cytology9biopsy is the only way to detect those lesions and should be
performed systematically in HIVMSM. Risk factor for AIN2was a nadir CD4B100/ml. A normal cytology was associated with
an undetectable VL and a longer duration of HAART. Those results provide further argument for early initiation of HAART.
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